IP Verse

Dry Powder Composition Comprising Co-Jet Milled Particles For Pulmonary Inhalation - EP2286797

The patent EP2286797 was granted to Vectura on Jan 26, 2022. The application was originally filed on Sep 15, 2004 under application number EP10181354A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2286797

VECTURA
Application Number
EP10181354A
Filing Date
Sep 15, 2004
Status
Patent Maintained As Amended
Dec 24, 2021
Grant Date
Jan 26, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSDec 14, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO0243701
DESCRIPTIONWO9623485
DESCRIPTIONWO9703649
EXAMINATIONWO9703649
OPPOSITIONDE10061932
OPPOSITIONEP1048295
OPPOSITIONUS4895726
OPPOSITIONWO0061108
OPPOSITIONWO0189492
OPPOSITIONWO0200197
OPPOSITIONWO0243701
OPPOSITIONWO2004089374
OPPOSITIONWO2004093848
OPPOSITIONWO9703649
SEARCHDE10061932
SEARCHEP1048295
SEARCHUS4895726
SEARCHWO0189492
SEARCHWO0200197
SEARCHWO2004089374
SEARCHWO2004093848

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- A.J. HICKEY, "Lung Deposition and Clearance of Pharmaceutical Aerosols: What Can Be Learned from Inhalation Toxicology and Industrial Hygiene?", Aerosol Science and Technology, (19930000), vol. 18, no. 3, pages 290 - 304
OPPOSITION- Anthony J. Hickey, "Chapter 14- Delivery of Drugs by the Pulmonary Route", Anthony J. Hickey, G.S. Banker and C.T. Rhodes, Modern Pharmaceutics, Fourth Edition, Revised and Expanded, Marcel Dekker, (20020000), vol. 121, pages 479 - 499
OPPOSITION- Anthony J. Hickey, "Chapter 14- Delivery of Drugs by the Pulmonary Route", Anthony J. Hickey, G.S. Banker and C.T. Rhodes, Modern Pharmaceutics, Fourth Edition, Revised and Expanded, Marcel Dekker, (20020000), vol. 121, pages 479 - 499, XP055539048
OPPOSITION- BYRON P R; DALBY R N; HICKEY A J, "OPTIMIZED INHALATION AEROSOLS I. THE EFFECTS OF SPHERICAL BAFFLE SIZE AND POSITION UPON THE OUTPUT OF SEVERAL PRESSURIZED NONAQUEOUS SUSPENSION FORMULATIONS", Pharmaceutical Research,, (19890000), vol. 6, pages 225 - 229
OPPOSITION- "Chapter 5 (partly)", Xian Ming Zeng; Et Al, Particle interactions in dry powder formulations for inhalation, London and New York, Taylor & Francis, (20010000), pages 133 - 138
OPPOSITION- "Chapter 5 (partly)", Xian Ming Zeng; Et Al, Particle interactions in dry powder formulations for inhalation, London and New York, Taylor & Francis, (20010000), pages 133 - 138, XP055412006
OPPOSITION- N.R. LABIRIS et al., "Pulmonary drug delivery.Part II: the role of inhalant dellivery devices and drug formulations in therapeutic effectiveness of aerosolized medications", Br. J. Clin. Pharmacol., (20030000), vol. 56, pages 600 - 612
OPPOSITION- R.J. MALCOMSON et al., "Dry powder formulations for pulmonary delivery", PSTT, (19981200), vol. 1, no. 9, pages 394 - 398
OPPOSITION- Robert E O`Connor, Joseph B Schwartz, "Chapter 37- Powders", Robert E O`Connor, Joseph B Schwartz, Alfonso R Gennaro, Remington: The Science and Practice of Pharmacy, 20th Edition, Lippincott Williams & Wilkins, (20000000), pages 681 - 685
OPPOSITION- Robert E O`Connor, Joseph B Schwartz, "Chapter 37- Powders", Robert E O`Connor, Joseph B Schwartz, Alfonso R Gennaro, Remington: The Science and Practice of Pharmacy, 20th Edition, Lippincott Williams & Wilkins, (20000000), pages 681 - 685, XP055539086
OPPOSITION- R.J. MALCOMSON et al., "Dry powder formulations for pulmonary delivery", PSTT, (19981200), vol. 1, no. 9, pages 394 - 398, XP001205507
OPPOSITION- BYRON P R; DALBY R N; HICKEY A J, "OPTIMIZED INHALATION AEROSOLS I. THE EFFECTS OF SPHERICAL BAFFLE SIZE AND POSITION UPON THE OUTPUT OF SEVERAL PRESSURIZED NONAQUEOUS SUSPENSION FORMULATIONS", Pharmaceutical Research,, (19890000), vol. 6, pages 225 - 229, XP002944462
OPPOSITION- N.R. LABIRIS et al., "Pulmonary drug delivery.Part II: the role of inhalant dellivery devices and drug formulations in therapeutic effectiveness of aerosolized medications", Br. J. Clin. Pharmacol., (20030000), vol. 56, pages 600 - 612, XP002440030
OPPOSITION- A.J. HICKEY, "Lung Deposition and Clearance of Pharmaceutical Aerosols: What Can Be Learned from Inhalation Toxicology and Industrial Hygiene?", Aerosol Science and Technology, (19930000), vol. 18, no. 3, pages 290 - 304, XP055539066

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents